Lenalidomide Delays Progression in Smoldering Multiple Myeloma

THURSDAY, Nov. 7, 2019 -- Lenalidomide significantly delays progression to symptomatic multiple myeloma in patients with smoldering multiple myeloma, according to a study published online Oct. 25 in the Journal of Clinical Oncology. Sagar Lonial,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news